कोशिश गोल्ड - मुक्त

Global Investors Ready to Pay for Assets With Better ESG

Mint New Delhi

|

January 13, 2025

A&M is rapidly expanding since it offers a mix of restructuring, forensics and deal-making

- Mansi Verma & Ranjani Raghavan

Global investors are increasingly prioritizing assets with a strong environmental, social and governance (ESG) footprint, driving up their value and putting ESG at the forefront of deal-making strategies in India, according to a top executive of global transaction advisory firm Alvarez & Marsal (A&M).

"If you're buying into a company with a better ESG footprint, the market's going to put a greater premium on that when you go to exit... I have clients who in their post-transaction value creation blueprint require ESG as part of that," Paul Aversano, managing director and global practice leader of A&M's global transaction advisory group, told Mint in an interaction during his recent visit to India.

Aversano co-founded and leads the firm's global transaction services group, US corporate M&A (mergers and acquisitions) transactions group and the US ESG business. "85-90% of the financial buyers said they were willing to pay more for a company that had an improved ESG footprint. Doing well financially as a business is also not mutually exclusive to doing well in other areas," he added.

Mint New Delhi से और कहानियाँ

Mint New Delhi

Mint New Delhi

How CCI plans to watch AI use by companies

The Competition Commission of India (CCI) on Monday proposed a self-audit for companies to keep track of how they use artificial intelligence (AI) and the data they train AI models on. Implementing such a practice comes with multiple caveats. Mint explains.

time to read

2 mins

October 08, 2025

Mint New Delhi

Mint New Delhi

NAVIGATING A JOB LOSS IS NOT AS HARD AS IT SEEMS, BUT YOU SHOULD START EARLY

The best time to mend the roof is when the sun is shining, not after the rains commence. There is so much wisdom in this one sentence that it needs careful reflection. People expect life to be a smooth, sedate, upward ride, but it is anything but that. In fact, every facet of life has its ups and downs - sometimes, they are positive and at other times, they may be challenging.

time to read

3 mins

October 08, 2025

Mint New Delhi

US TARIFF-LED RISKS PERSIST FOR INDIA

The Indian economy stumbled in August, hit by the US's additional 25% tariffs on top of the 25% reciprocal levy, as external risks weighed on domestic momentum through a weakening rupee, continued selling by foreign investors, sliding stock market and slowing exports.

time to read

3 mins

October 08, 2025

Mint New Delhi

Nykaa fashion arm sashays again—spotlight on the stride

The fashion business of FSN E-Commerce Ventures Ltd (Nykaa) is showing signs of revival after several quarters of modest performance.

time to read

1 mins

October 08, 2025

Mint New Delhi

Mint New Delhi

‘RBI focusing on new use cases for e-rupee’

The Reserve Bank of India (RBI) is in no rush to open up the pilots for the central bank digital currency (CBDC) to the masses and is, instead, focusing on adding more use cases to the e-rupee with a focus on cross-border transactions, T. Rabi Sankar, deputy governor of the central bank, said on Tuesday.

time to read

1 mins

October 08, 2025

Mint New Delhi

Nobel physics prize goes to pioneers of quantum mechanics

US-based scientists John Clarke, Michel Devoret and John Martinis won the 2025 Nobel Prize in Physics for “experiments that revealed quantum physics in action”, paving the way for the development of the next generation of digital technologies.

time to read

1 min

October 08, 2025

Mint New Delhi

Nvidia to continue sponsoring H-1B visas

Chipmaker Nvidia's CEO Jensen Huang said that the company will continue to sponsor H-IB visas and cover all associated costs following U.S. President Donald Trump's executive order last month that imposed a $100,000 fee on each new application, Business Insider reported on Tuesday.

time to read

1 min

October 08, 2025

Mint New Delhi

AstraZeneca to sell cancer drug in India

AstraZeneca Pharma on Tuesday said it has received approval from the national drug regulator to market a cancer treatment drug in the country.

time to read

1 min

October 08, 2025

Mint New Delhi

Fintech lending growth slows after clampdown

But delinquency and deep-stage stress are still elevated, shows report

time to read

2 mins

October 08, 2025

Mint New Delhi

CENTRAL BANK OF INDIA RATED INDIA INVOLVED BY SKOCH FOR TRANSFORMING RECRUITMENT ONBOARDING DIGITALLY

The Central Bank of India has undertaken a landmark initiative to reimagine its recruitment and onboarding practices through a comprehensive digital solution.

time to read

1 mins

October 08, 2025

Listen

Translate

Share

-
+

Change font size